At Oncology Practice Management, we believe novel oncology medicines coupled with robust patient support programs drive progress in cancer care.
Innovations in cancer research yielded multiple novel oncology drugs over the past year. Innovations in patient support programs continue to ensure patient access to these medicines as well as access to the resources that keep patients encouraged, empowered, and engaged in their own care.
We are pleased to highlight the 2021 FDA-approved oncology drugs and their accompanying patient support programs in the hope of promoting participation and supporting the best possible outcomes.
Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?
Help us fix it! Report broken links here.
Report Broken Links
Submit